{"id":40816,"date":"2021-10-05T15:47:17","date_gmt":"2021-10-05T22:47:17","guid":{"rendered":"https:\/\/lapost.us\/?p=40816"},"modified":"2021-10-05T15:47:17","modified_gmt":"2021-10-05T22:47:17","slug":"another-fda-request-astrazenecas-covid-19-preventative-treatment","status":"publish","type":"post","link":"https:\/\/lapost.us\/?p=40816","title":{"rendered":"ANOTHER FDA REQUEST: ASTRAZENECA&#8217;S COVID-19 PREVENTATIVE TREATMENT"},"content":{"rendered":"<p dir=\"ltr\">AstraZeneca also submitted a request for emergency use authorization on Tuesday \u2014 for an antibody drug designed to help prevent symptomatic COVID-19.<\/p>\n<p dir=\"ltr\">The antibody therapy, called AZD7442, provides \u201cstatistically significant reduction\u201d in the risk of developing COVID-19 and could provide another protective measure for vulnerable populations, including the immunocompromised, against the deadly disease, the company\u00a0<a href=\"https:\/\/click1.email.thehill.com\/hqfmjlnrfvvzdldvzscffzmmfnzpvnvggwfrlhpvbnsmnm_hsqvccbqbzvwbbshvhch.html?a=&amp;b=43009\" target=\"_blank\" rel=\"noopener noreferrer\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/click1.email.thehill.com\/hqfmjlnrfvvzdldvzscffzmmfnzpvnvggwfrlhpvbnsmnm_hsqvccbqbzvwbbshvhch.html?a%3D%26b%3D43009&amp;source=gmail&amp;ust=1633558346338000&amp;usg=AFQjCNFlX3x2NDXIt5G61FPcPzNqFKkiBA\">said in a statement<\/a>.<\/p>\n<p dir=\"ltr\">In its application to the Food and Drug Administration (FDA), AstraZeneca cited data from a trial showing the drug was 77 percent effective at thwarting symptomatic COVID-19. More than three-quarters of the tested population were immunocompromised or had other comorbidities associated with serious illness.<\/p>\n<p dir=\"ltr\"><strong>Significance:<\/strong>\u00a0If the FDA grants emergency use authorization for the drug, it will be the first long-acting antibody cocktail to receive such approval for COVID-19 prevention, the company said.<\/p>\n<p dir=\"ltr\">Mene Pangalos, AstraZeneca&#8217;s head of biopharmaceuticals research, said the antibody combination will help people who do not have a fully immune response to COVID-19 vaccines and need more to adequately prevent infections.<\/p>\n<p dir=\"ltr\">&#8220;With this first global regulatory filing, we are one step closer to providing an additional option to help protect against COVID-19 alongside vaccines,&#8221; Pangalos said in the release.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>AstraZeneca also submitted a request for&#46;&#46;&#46;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[],"class_list":["post-40816","post","type-post","status-publish","format-standard","hentry","category-health"],"_links":{"self":[{"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/posts\/40816","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lapost.us\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=40816"}],"version-history":[{"count":1,"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/posts\/40816\/revisions"}],"predecessor-version":[{"id":40817,"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/posts\/40816\/revisions\/40817"}],"wp:attachment":[{"href":"https:\/\/lapost.us\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=40816"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lapost.us\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=40816"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lapost.us\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=40816"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}